Phase 3CompletedAge-related condition
A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males
A Phase 3, Open-Label, Non-Randomized, Clinical Trial to Evaluate the Efficacy and Safety of FE 999303 (Testosterone Gel) in Adult Hypogonadal Males
- Sponsor
- Ferring Pharmaceuticals (Industry)
- Enrolment
- 160 enrolled
- Conditions
- Adult Male Hypogonadism
- Interventions
- Testosterone gel (FE 999303)
- Ages
- adults, older adults
- Registry
- NCT02149264
Full record on ClinicalTrials.gov
From the registry
This is a phase 3, open-label, non-randomized, clinical trial to evaluate the efficacy and safety of FE 999303 (Testosterone gel) in adult hypogonadal males.
Primary outcomes
- The Percentage of Subjects Whose Average Concentration (Cave(0-24)) Serum Total Testosterone Levels Are ≥300 and ≤1050 ng/dL
History
Last registry update
Results first posted
Study completion
Primary completion
Started
Registered